LIGORIO, FRANCESCA

LIGORIO, FRANCESCA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 1-gen-2021 Ligorio F.Zambelli L.Bottiglieri A.Zattarin E.Ottini A.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 1-gen-2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin 1-mar-2021 Fabbroni C.Ligorio F.Casali P. G.Sanfilippo R. + Article (author) -
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 1-apr-2021 Ligorio F.Zattarin E.Lobefaro R.Zambelli L.Leporati R.de Braud F. + Article (author) -
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report 1-dic-2021 Zattarin E.Ligorio F.Nichetti F.de Braud F. + Article (author) -
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 1-gen-2021 Ligorio F.Pellegrini I.Castagnoli L.Vingiani A.Lobefaro R.Zattarin E.Pruneri G.de Braud F.Vernieri C. + Article (author) -
Wave climate at shallow waters along the Abu Dhabi coast 1-gen-2018 Ligorio F.D'Alessandro F. + Article (author) -